Search alternatives:
we decrease » _ decrease (Expand Search), mean decrease (Expand Search), teer decrease (Expand Search)
ng decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
2 we » 2 e (Expand Search), 2 de (Expand Search), _ we (Expand Search)
we decrease » _ decrease (Expand Search), mean decrease (Expand Search), teer decrease (Expand Search)
ng decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
2 we » 2 e (Expand Search), 2 de (Expand Search), _ we (Expand Search)
-
12441
Image_1_Longitudinal Analysis of Antibody Responses to the mRNA BNT162b2 Vaccine in Patients Undergoing Maintenance Hemodialysis: A 6-Month Follow-Up.pdf
Published 2021“…</p><p>Methods: We performed a prospective, 6-month long longitudinal cohort analysis of 156 HD patients scheduled to receive BTN162b2. …”
-
12442
Table_8_Longitudinal Analysis of Antibody Responses to the mRNA BNT162b2 Vaccine in Patients Undergoing Maintenance Hemodialysis: A 6-Month Follow-Up.pdf
Published 2021“…</p><p>Methods: We performed a prospective, 6-month long longitudinal cohort analysis of 156 HD patients scheduled to receive BTN162b2. …”
-
12443
Presentation_1_Longitudinal Analysis of Antibody Responses to the mRNA BNT162b2 Vaccine in Patients Undergoing Maintenance Hemodialysis: A 6-Month Follow-Up.pdf
Published 2021“…</p><p>Methods: We performed a prospective, 6-month long longitudinal cohort analysis of 156 HD patients scheduled to receive BTN162b2. …”
-
12444
Table_4_Longitudinal Analysis of Antibody Responses to the mRNA BNT162b2 Vaccine in Patients Undergoing Maintenance Hemodialysis: A 6-Month Follow-Up.pdf
Published 2021“…</p><p>Methods: We performed a prospective, 6-month long longitudinal cohort analysis of 156 HD patients scheduled to receive BTN162b2. …”
-
12445
Table_3_Longitudinal Analysis of Antibody Responses to the mRNA BNT162b2 Vaccine in Patients Undergoing Maintenance Hemodialysis: A 6-Month Follow-Up.pdf
Published 2021“…</p><p>Methods: We performed a prospective, 6-month long longitudinal cohort analysis of 156 HD patients scheduled to receive BTN162b2. …”
-
12446
Table_1_Longitudinal Analysis of Antibody Responses to the mRNA BNT162b2 Vaccine in Patients Undergoing Maintenance Hemodialysis: A 6-Month Follow-Up.XLSX
Published 2021“…</p><p>Methods: We performed a prospective, 6-month long longitudinal cohort analysis of 156 HD patients scheduled to receive BTN162b2. …”
-
12447
Table_9_Longitudinal Analysis of Antibody Responses to the mRNA BNT162b2 Vaccine in Patients Undergoing Maintenance Hemodialysis: A 6-Month Follow-Up.pdf
Published 2021“…</p><p>Methods: We performed a prospective, 6-month long longitudinal cohort analysis of 156 HD patients scheduled to receive BTN162b2. …”
-
12448
Table_13_Longitudinal Analysis of Antibody Responses to the mRNA BNT162b2 Vaccine in Patients Undergoing Maintenance Hemodialysis: A 6-Month Follow-Up.pdf
Published 2021“…</p><p>Methods: We performed a prospective, 6-month long longitudinal cohort analysis of 156 HD patients scheduled to receive BTN162b2. …”
-
12449
Table_12_Longitudinal Analysis of Antibody Responses to the mRNA BNT162b2 Vaccine in Patients Undergoing Maintenance Hemodialysis: A 6-Month Follow-Up.pdf
Published 2021“…</p><p>Methods: We performed a prospective, 6-month long longitudinal cohort analysis of 156 HD patients scheduled to receive BTN162b2. …”
-
12450
Table_6_Longitudinal Analysis of Antibody Responses to the mRNA BNT162b2 Vaccine in Patients Undergoing Maintenance Hemodialysis: A 6-Month Follow-Up.pdf
Published 2021“…</p><p>Methods: We performed a prospective, 6-month long longitudinal cohort analysis of 156 HD patients scheduled to receive BTN162b2. …”
-
12451
Table_11_Longitudinal Analysis of Antibody Responses to the mRNA BNT162b2 Vaccine in Patients Undergoing Maintenance Hemodialysis: A 6-Month Follow-Up.pdf
Published 2021“…</p><p>Methods: We performed a prospective, 6-month long longitudinal cohort analysis of 156 HD patients scheduled to receive BTN162b2. …”
-
12452
S5 Fig -
Published 2024“…(<b>B</b>) Cells as indicated were seeded at similar density, treated or not with Blasticidin (used here as a control to decrease cell viability), and cultured for 4 days before resazurin cell viability assay. …”
-
12453
-
12454
Folic acid: a potential inhibitor against SARS-CoV-2 nucleocapsid protein
Published 2022“…This effect was decreased by 8.0% in the presence of SARS-CoV-2 N, indicating that SARS-CoV-2 N inhibits RNAi. …”
-
12455
Anti-C5a reduced IL-12<sup>+</sup>DCs in PBMC and LN.
Published 2013“…<p>(<b>A and B</b>) <b>IL-12<sup>+</sup>DCs cells decreased in PBMC and LN from anti-C5a-treated sepsis.…”
-
12456
-
12457
-
12458
A model of the role of CRH-1 in ascr#5-mediated L2d formation.
Published 2021“…<p>CRH-1 positively regulates dauer-inhibiting <i>daf-7</i> TGF-β expression in the ascr#5-sensing ASI neurons. In <i>crh-1</i> mutants, the decreased <i>daf-7</i> TGF-β expression provides a sensitized genetic background for further ascr#5-mediated <i>daf-7</i> TGF-β repression via <i>srg-36/37</i> GPCRs which leads to transient L2d formation and <i>flp-8</i> expression of AAP-TRN.…”
-
12459
Table_1_Immune modulation as a consequence of SARS-CoV-2 infection.docx
Published 2022“…NK cell subsets and cytotoxic capacity of NK cells were decreased in severe patients. Moreover, CD3<sup>+</sup> T cells were reduced in severe patients and a negative correlation was found between CD3<sup>+</sup> T cells and D-dimer levels. …”
-
12460